Consistent with these findings, the hypermethylation we observed at TMEM232 associated with greater CR may suggest that reducing TMEM232-mediated inflammatory signaling could contribute to a peripheral immune environment that mitigates the impact of AD pathology. This evidence concerns the gene TMEM232 and Alzheimer disease.